In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms

More than 50 years ago, the first concepts for gastroretentive drug delivery systems were developed. Despite extensive research in this field, there is no single formulation concept for which reliable gastroretention has been demonstrated under different prandial conditions. Thus, gastroretention re...

Full description

Bibliographic Details
Published in:Pharmaceutics
Main Authors: Felix Schneider, Mirko Koziolek, Werner Weitschies
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Subjects:
Online Access:https://www.mdpi.com/1999-4923/11/8/416
_version_ 1851938612193525760
author Felix Schneider
Mirko Koziolek
Werner Weitschies
author_facet Felix Schneider
Mirko Koziolek
Werner Weitschies
author_sort Felix Schneider
collection DOAJ
container_title Pharmaceutics
description More than 50 years ago, the first concepts for gastroretentive drug delivery systems were developed. Despite extensive research in this field, there is no single formulation concept for which reliable gastroretention has been demonstrated under different prandial conditions. Thus, gastroretention remains the holy grail of oral drug delivery. One of the major reasons for the various setbacks in this field is the lack of predictive in vitro and in vivo test methods used during preclinical development. In most cases, human gastrointestinal physiology is not properly considered, which leads to the application of inappropriate in vitro and animal models. Moreover, conditions in the stomach are often not fully understood. Important aspects such as the kinetics of fluid volumes, gastric pH or mechanical stresses have to be considered in a realistic manner, otherwise, the gastroretentive potential as well as drug release of novel formulations cannot be assessed correctly in preclinical studies. This review, therefore, highlights the most important aspects of human gastrointestinal physiology and discusses their potential implications for the evaluation of gastroretentive drug delivery systems.
format Article
id doaj-art-9a4e45ec8fe848da80d58dba400a0f82
institution Directory of Open Access Journals
issn 1999-4923
language English
publishDate 2019-08-01
publisher MDPI AG
record_format Article
spelling doaj-art-9a4e45ec8fe848da80d58dba400a0f822025-08-19T21:51:16ZengMDPI AGPharmaceutics1999-49232019-08-0111841610.3390/pharmaceutics11080416pharmaceutics11080416In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage FormsFelix Schneider0Mirko Koziolek1Werner Weitschies2Department of Biopharmaceutics and Pharmaceutical Technology, Institute of Pharmacy, University of Greifswald, 17489 Greifswald, GermanyDepartment of Biopharmaceutics and Pharmaceutical Technology, Institute of Pharmacy, University of Greifswald, 17489 Greifswald, GermanyDepartment of Biopharmaceutics and Pharmaceutical Technology, Institute of Pharmacy, University of Greifswald, 17489 Greifswald, GermanyMore than 50 years ago, the first concepts for gastroretentive drug delivery systems were developed. Despite extensive research in this field, there is no single formulation concept for which reliable gastroretention has been demonstrated under different prandial conditions. Thus, gastroretention remains the holy grail of oral drug delivery. One of the major reasons for the various setbacks in this field is the lack of predictive in vitro and in vivo test methods used during preclinical development. In most cases, human gastrointestinal physiology is not properly considered, which leads to the application of inappropriate in vitro and animal models. Moreover, conditions in the stomach are often not fully understood. Important aspects such as the kinetics of fluid volumes, gastric pH or mechanical stresses have to be considered in a realistic manner, otherwise, the gastroretentive potential as well as drug release of novel formulations cannot be assessed correctly in preclinical studies. This review, therefore, highlights the most important aspects of human gastrointestinal physiology and discusses their potential implications for the evaluation of gastroretentive drug delivery systems.https://www.mdpi.com/1999-4923/11/8/416gastroretentiongastroretentive dosage formsin vitro testingdrug releasein vivo studies
spellingShingle Felix Schneider
Mirko Koziolek
Werner Weitschies
In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms
gastroretention
gastroretentive dosage forms
in vitro testing
drug release
in vivo studies
title In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms
title_full In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms
title_fullStr In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms
title_full_unstemmed In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms
title_short In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms
title_sort in vitro and in vivo test methods for the evaluation of gastroretentive dosage forms
topic gastroretention
gastroretentive dosage forms
in vitro testing
drug release
in vivo studies
url https://www.mdpi.com/1999-4923/11/8/416
work_keys_str_mv AT felixschneider invitroandinvivotestmethodsfortheevaluationofgastroretentivedosageforms
AT mirkokoziolek invitroandinvivotestmethodsfortheevaluationofgastroretentivedosageforms
AT wernerweitschies invitroandinvivotestmethodsfortheevaluationofgastroretentivedosageforms